Literature DB >> 23742884

Guidelines for the diagnosis and treatment of idiopathic pulmonary fibrosis. Sociedad Española de Neumología y Cirugía Torácica (SEPAR) Research Group on Diffuse Pulmonary Diseases.

Antoni Xaubet1, Julio Ancochea, Elena Bollo, Estrella Fernández-Fabrellas, Tomás Franquet, Maria Molina-Molina, Maria Angeles Montero, Anna Serrano-Mollar.   

Abstract

Idiopathic pulmonary fibrosis is defined as a chronic fibrosing interstitial pneumonia limited to the lung, of unknown cause, with poor prognosis and few treatment options. In recent years there has been an increase in their prevalence, probably due to the optimization of diagnostic methods and increased life expectancy. The ATS/ERS Consensus (2000) established the diagnostic criteria and recommendations for the assessment of the disease course and treatment. Later studies have helped to redefine diagnostic criteria and treatment options. In 2011, an international consensus was published, establishing diagnostic criteria and new treatment strategies. These guidelines have been updated with the newest aspects of diagnosis and treatment of idiopathic pulmonary fibrosis. A level of evidence has been identified for the most relevant questions, particularly with regard to treatment options.
Copyright © 2012 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Diagnosis; Diagnóstico; Fibrosis pulmonar idiopática; Idiopathic pulmonary fibrosis; Tratamiento; Treatment

Mesh:

Substances:

Year:  2013        PMID: 23742884     DOI: 10.1016/j.arbres.2013.03.011

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  13 in total

1.  Nickle(II) ions exacerbate bleomycin-induced pulmonary inflammation and fibrosis by activating the ROS/Akt signaling pathway.

Authors:  Lawei Yang; Ziying Lin; Yahong Wang; Chunyan Li; Wenya Xu; Qinglan Li; Weimin Yao; Zeqing Song; Gang Liu
Journal:  Environ Sci Pollut Res Int       Date:  2017-11-28       Impact factor: 4.223

Review 2.  Pirfenidone: a review of its use in idiopathic pulmonary fibrosis.

Authors:  Esther S Kim; Gillian M Keating
Journal:  Drugs       Date:  2015-02       Impact factor: 9.546

Review 3.  Viruses in Idiopathic Pulmonary Fibrosis. Etiology and Exacerbation.

Authors:  Bethany B Moore; Thomas A Moore
Journal:  Ann Am Thorac Soc       Date:  2015-11

4.  Effectiveness and safety of pirfenidone for idiopathic pulmonary fibrosis.

Authors:  Borja Marcos Ribes; José N Sancho-Chust; Amparo Talens; Mar Arlandis; Paola Herraiz; Eusebi Chiner; Teresa Aznar
Journal:  Eur J Hosp Pharm       Date:  2019-05-07

Review 5.  Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis.

Authors:  Yoshito Takeda; Kazuyuki Tsujino; Takashi Kijima; Atsushi Kumanogoh
Journal:  Patient Prefer Adherence       Date:  2014-03-21       Impact factor: 2.711

Review 6.  Efficacy of N-Acetylcysteine in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.

Authors:  Tong Sun; Jing Liu; De Wei Zhao
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

7.  Transbronchial cryobiopsy in interstitial lung disease: experience in 106 cases - how to do it.

Authors:  Antonio Bango-Álvarez; Miguel Ariza-Prota; Hector Torres-Rivas; Luis Fernández-Fernández; Amador Prieto; Inmaculada Sánchez; Maria Gil; Ana Pando-Sandoval
Journal:  ERJ Open Res       Date:  2017-03-22

Review 8.  Efficacy of antioxidant in idiopathic pulmonary fibrosis: A systematic review and meta-analysis.

Authors:  Amit D Kandhare; Anwesha Mukherjee; Pinaki Ghosh; Subhash L Bodhankar
Journal:  EXCLI J       Date:  2016-11-07       Impact factor: 4.068

9.  Management and attitudes about IPF (Idiopathic Pulmonary Fibrosis) among physicians from Latin America.

Authors:  Iván Cherrez-Ojeda; Vincent Cottin; Juan Carlos Calderón; César Delgado; Erick Calero; Daniel Simanca-Racines; Silvia Quadrelli; Annia Cherrez
Journal:  BMC Pulm Med       Date:  2018-01-10       Impact factor: 3.317

Review 10.  Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis.

Authors:  Estrella Fernández Fabrellas; Ricardo Peris Sánchez; Cristina Sabater Abad; Gustavo Juan Samper
Journal:  Med Sci (Basel)       Date:  2018-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.